Hematology, Hemostasis, & Urinalysis
|2 min read
FDA Expands Casgevy Gene Therapy to Children 2+ with Sickle Cell Disease and β Thalassemia
FDA approval extends CRISPR-based Casgevy to pediatric patients aged 2 and older, broadening access for sickle cell disease and transfusion-dependent β thalassemia.
|2 min read
Labcorp Launches FDA-Cleared 10-Minute Rapid Fentanyl Urine Test
New point-of-care test detects fentanyl metabolite norfentanyl, extending detection up to 48 hours to support faster clinical decisions in acute care settings
|2 min read
CAP Updates Cancer Protocols, Clarifies MMR/MSI Testing Discordance in New Article
The updates underscore shifts toward more standardized cancer reporting and more integrated interpretation of MMR/MSI testing in clinical decision-making
|2 min read
ASH Releases Guidelines for Severe Acquired Aplastic Anemia Diagnosis and Management
Recommendations outline best practices for diagnosing and managing the rare and life-threatening condition in children and adults
|3 min read
Body’s Immune Response May Keep HIV in Check Without Medication
Study finds antibodies and T cells can suppress HIV in some patients without lifelong medication, opening the door to new treatment strategies
|2 min read
Gut Microbiome Connected with Heart Disease Precursor
Using metagenomic sequencing, a new study reports a gut microbiome signature associated with dyslipidemia
|3 min read
Direct-to-Consumer Gut Microbiome Testing Kit Results Vary Between Kits and Manufacturers
The accuracy of gut health tests remains uncertain and no study has systematically evaluated their performance until now
|3 min read
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients
|1 min read
Move Past the Limitations of Synthetic Reference Standards in Cancer Research
A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignanciesSponsored by
|3 min read
Improving the Diagnosis and Assessment of Castleman Disease
New efforts aim to overcome diagnostic and histologic challenges in Castleman disease
|3 min read
Rethinking UTI Diagnostics: Getting to the Right Therapy the First Time
Urine cultures remain essential, but molecular diagnostics are narrowing the gap between testing and treatment for urinary tract infections
|2 min read
New Mechanism Links Epstein-Barr Virus to Multiple Sclerosis
Exactly how Epstein-Barr virus contributes to MS has long been unclear
|3 min read
